Mylab leverages’s tech to enhance TB screening

Indian biotech company Mylab Discovery Solutions is integrating’s AI technology into its upcoming x-ray device for screening tuberculosis.

According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by’s deep-learning software qXR to analyse chest x-ray images and identify TB within a minute. 


India is one of the biggest contributors to global TB cases, accounting for 26% of the total global count and 34% of all TB deaths.

By leveraging technological innovation, both Mylab and aim to support the Indian government’s goal of eliminating TB by 2025. Their integrated solution, said Mylab, will help broaden access to screening services among at-risk populations. It can be most beneficial in remote settings where there is also a lack of diagnostic resources. 

Aside from augmenting TB screening capabilities, it can also help relieve pressure on health facilities when it comes to identifying presumptive TB cases.

“[W]ith’s power of deep learning for radiology, the process will become much faster, more objective and scalable,” claimed Mylab managing director and co-founder Hasmukh Rawal.


This is not the first time that the qXR, a WHO-recommended and CE-marked solution for the preliminary detection of TB, has been used to support the expansion of TB screening in India. In 2021, Fujifilm India started collaborating with to integrate its AI software into the Fujifilm X-ray FDR Xair system. 

Meanwhile, VinBrain, a medical AI software developer in Vietnam, recently developed an AI model for detecting TB. The said model, which has shown high sensitivity and specificity in reading chest x-rays for TB diagnosis, has been integrated into VinBrain’s DrAid platform.

You may also like


Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties